1. Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
   Katarzyna Węgierek-Ciura et al, 2023, Frontiers in Immunology CrossRef
2. Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
   Agnieszka Szczygieł et al, 2023, Frontiers in Immunology CrossRef